SIRT1 Disruption in Human Fetal Hepatocytes Leads to Increased Accumulation of Glucose and Lipids
Takamasa Tobita(University of Pittsburgh), Alejandro Soto–Gutiérrez(Children's Hospital of Pittsburgh), Toshimasa Nakao(University of Pittsburgh), Kazuki Takeishi(University of Pittsburgh), Alexandra Collin de l’Hortet(Délégation Paris 5), Yang Wang(University of Pittsburgh), Jorge Guzman‐Lepe(University of Pittsburgh), Chu-Xia Deng(University of Macau), Fanying Meng(Shanghai University)
Cited by 47
Related Papers
Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
|Molecular Cancer Therapeutics|2011|206
PuraMatrix™ Facilitates Bone Regeneration in Bone Defects of Calvaria in Mice
|Cell Transplantation|2006|116
Human biomimetic liver microphysiology systems in drug development and precision medicine
|Nature Reviews Gastroenterology & Hepatology|2020|111
Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis
|Journal of Clinical Investigation|2022|57
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL
|Clinical Cancer Research|2019|53